We are thrilled to announce our beloved Camu Camu capsules have been chosen by the University of Montreal to do another Health Canada-approved study! Our Camu Camu was previously used in a study by Université Laval in Québec City to examine its impact on metabolism, which was shown to help fight against obesity and metabolic disease.
This spring, The University of Montreal will be conducting a study on the effect of Camu Camu combined with immunotherapy in patients with lung cancer and melanoma. The final report of the results of this study will be available by 2027.
Castalagin is a plant compound derived from the Camu Camu berry, which has an anti-tumor effect when combined with commensal bacteria, thus reprogramming the tumor microenvironment. This interaction creates a more than ideal circumstance to test Castalagin in a clinical trial. Our Camu Camu capsules were chosen by the University of Montreal for their high quality ingredients and high Castalagin content.
Aside from its anti-tumor effects, Camu Camu has been shown to have a plethora of health benefits, including but not limited to: fighting inflammation, boosting immunity, combating fatigue and improving gut health, all due to its high vitamin C and antioxidant content.
To read the clinical trial webpage, click here.